Document Type
Article
Publication Date
1-7-2022
Publication Title
Lab Anim Res
Keywords
JMG
JAX Source
Lab Anim Res 2022 Jan 7; 38(1):1
Volume
38
Issue
1
First Page
1
Last Page
1
ISSN
1738-6055
PMID
34996527
DOI
https://doi.org/10.1186/s42826-021-00111-2
Grant
HL077796, HL095668
Abstract
BACKGROUND: The convertase subtilisin/kexin family 1 gene (PCSK1) has been associated in various human genetics studies with a wide spectrum of metabolic phenotypes, including early-onset obesity, hyperphagia, diabetes insipidus, and others. Despite the evident influence of PCSK1 on obesity and the known functions of other PCSKs in lipid metabolism, the role of PCSK1 specifically in lipid and cholesterol metabolism remains unclear. This study evaluated the effect of loss of PCSK1 function on high-density lipoprotein (HDL) metabolism in mice.
RESULTS: HDL cholesterol, apolipoprotein A1 (APOA1) levels in serum and liver, and the activities of two enzymes (lecithin-cholesterol acyltransferase, LCAT and phospholipid transfer protein, PLTP) were evaluated in 8-week-old mice with a non-synonymous single nucleotide mutation leading to an amino acid substitution in PCSK1, which results in a loss of protein's function. Mutant mice had similar serum HDL cholesterol concentration but increased levels of serum total and mature APOA1, and LCAT activity in comparison to controls.
CONCLUSIONS: This study presents the first evaluation of the role of PCSK1 in HDL metabolism using a loss-of-function mutant mouse model. Further investigations will be needed to determine the underlying molecular mechanism.
Recommended Citation
Khan A,
Kim N,
Korstanje R,
Choi S.
Loss-of-function mutation in Pcsk1 increases serum APOA1 level and LCAT activity in mice. Lab Anim Res 2022 Jan 7; 38(1):1
Comments
In memory of Beverly Paigen (1938-2020). We thank Joanne Currer for editorial advice; Kyle Beauchemin, George Sutphin, Christopher McCarty, and Elisabeth Adkins for scientific discussion and feedback; Beverly Macy and Rachel Gott for animal care and serum collection; Sue Grindle for HDL cholesterol measurement; Susan Sheehan and Kenneth Walsh for general technical support.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License.